This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
This template is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
This template does not require a rating on Wikipedia's content assessment scale.
Women's Health on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women's HealthWikipedia:WikiProject Women's HealthTemplate:WikiProject Women's Healthwomen's health articles
First graph's source: How were these E2 levels measured premenopause?
Since I can't access the Kuhnz 1993 PMID 8240460, I have to ask this template's contributor(s): If these are premenopausal women, how are they getting measured at T=0 as having zero endogenous estradiol? Why are they rising from zero as if the dosing was for a postmenopausal or orchiectomied female? -- The only way I could imagine this making sense is if the study were measuring radiolabeled E2 alone, but neither this graph's description nor the available Kuhnz abstract mention radiolabeling.
I suppose it could also be that the graph is supposed to represent increase in E2 above endogenous baseline, but the graph's description doesn't mention that either.
